177 related articles for article (PubMed ID: 3677678)
1. Influence of vitamin E administration on platelet functions in hormonal contraceptive users.
Renaud S; Ciavatti M; Perrot L; Berthezene F; Dargent D; Condamin P
Contraception; 1987 Sep; 36(3):347-58. PubMed ID: 3677678
[TBL] [Abstract][Full Text] [Related]
2. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
Norris LA; Devitt M; Bonnar J
Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis of platelet lipids in relation to aggregation in women using oral contraceptives.
Ciavatti M; Davenas E; Blache D; Monnier MA; Renaud S
Contraception; 1982 Jun; 25(6):629-38. PubMed ID: 7116849
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for coronary heart disease and platelet functions.
Renaud S
Adv Exp Med Biol; 1984; 164():129-44. PubMed ID: 6695570
[TBL] [Abstract][Full Text] [Related]
5. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
6. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
Horwitt MK; Harvey CC; Dahm CH
Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
[TBL] [Abstract][Full Text] [Related]
7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraceptive increases plasma lipid peroxides in female rats. Relationship to platelet aggregation and lipid biosynthesis.
Ciavatti M; Blache D; Renaud S
Arteriosclerosis; 1989; 9(1):84-9. PubMed ID: 2536271
[TBL] [Abstract][Full Text] [Related]
9. Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk.
Ciavatti M; Renaud S
Free Radic Biol Med; 1991; 10(5):325-38. PubMed ID: 1855673
[TBL] [Abstract][Full Text] [Related]
10. The in vitro effect of aspirin on increased whole blood platelet aggregation in oral contraceptive users.
Norris LA; Bonnar J
Thromb Res; 1994 May; 74(3):309-15. PubMed ID: 8042198
[TBL] [Abstract][Full Text] [Related]
11. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
Straznicky NE; Barrington VE; Branley P; Louis WJ
J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
[TBL] [Abstract][Full Text] [Related]
12. Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers.
Beisiegel B; Treese N; Hafner G; Meyer J; Darius H
Agents Actions Suppl; 1992; 37():183-9. PubMed ID: 1378684
[TBL] [Abstract][Full Text] [Related]
13. Hormonal contraception and platelet function.
Saleh AA; Ginsburg KA; Duchon TA; Dorey LG; Hirata J; Alshameeri RS; Dombrowski MP; Mammen EF
Thromb Res; 1995 May; 78(4):363-7. PubMed ID: 7631316
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
Kelleher CC
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
Moller SE; Moller BM; Olesen M; Fjalland B
Eur J Clin Pharmacol; 1996; 50(3):179-84. PubMed ID: 8737756
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
18. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E prevents the platelet abnormalities induced by estrogen in rat.
Ciavatti M; Davenas E; Blache D; Renaud S
Contraception; 1984 Sep; 30(3):279-87. PubMed ID: 6509982
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
Devenport MH; Crook D; Wynn V; Lees LJ
Br J Clin Pharmacol; 1989 Jun; 27(6):851-9. PubMed ID: 2547410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
